HYPERBARIC OXYGEN THERAPY IN THE TREATMENT OF DIABETIC FOOT ULCERS: COMPARISON WITH STANDARD CARE AND CURRENT CLINICAL EVIDENCE
DOI:
https://doi.org/10.31435/ijitss.1(49).2026.5299Keywords:
Diabetic Foot Ulcers (DFUs), Diabetic Foot Syndrome, Hyperbaric Oxygen Therapy (HBOT)Abstract
Background: Diabetic foot ulcers are a common and serious complication of diabetes, associated with high morbidity, higher healthcare costs, and an increased risk of lower limb amputation. Despite advances in standard wound care, a significant proportion of diabetic foot ulcers remain resistant to treatment, prompting interest in adjunctive therapies such as hyperbaric oxygen therapy.
Aim: The aim of this narrative review was to summarize and critically evaluate current evidence comparing HBOT with standard treatment modalities in patients with DFUs.
Material and methods: A structured literature search was conducted using PubMed and Google Scholar to identify randomized controlled trials, systematic reviews, meta-analyses, and clinical guidelines related to the treatment of diabetic foot ulcers and hyperbaric oxygen therapy. Relevant publications were analyzed and synthesized narratively, focusing on wound healing outcomes, amputation rates, and safety considerations.
Results: Evidence from RCTs suggests that HBOT may improve ulcer healing rates in patients with chronic, non-healing DFUs when used as an adjunct to standard care. Several meta-analyses indicate that HBOT is associated with increased rates of complete ulcer healing and a reduced risk of major amputations. However, findings from Cochrane reviews demonstrate that these benefits may be limited primarily to short-term outcomes, with inconsistent evidence regarding sustained long-term efficacy. HBOT was generally well tolerated, with adverse events being infrequent and mostly mild.
Conclusions: Current evidence suggests that HBOT may be beneficial as an adjunctive treatment in carefully selected patients with refractory DFUs. Nevertheless, heterogeneity among studies and methodological limitations preclude definitive conclusions regarding long-term outcomes. Further high-quality, standardized randomized trials are required to clarify the role of HBOT in routine clinical practice.
References
Braun, L., Kim, P. J., Margolis, D., Peters, E. J., & Lavery, L. A. (2014). What’s new in the literature: An update of new research since the original WHS diabetic foot ulcer guidelines in 2006. Wound Repair and Regeneration, 22(5), 594–604. https://doi.org/10.1111/wrr.12220
Bellomo, T. R., Lee, S., McCarthy, M., Tong, K. P. S., Ferreira, S. S., Cheung, T. P., & Rose-Sauld, S. (2022). Management of the diabetic foot. Seminars in Vascular Surgery, 35(2), 219–227. https://doi.org/10.1053/j.semvascsurg.2022.04.002
Deng, H., Li, B., Shen, Q., Zhang, C., Kuang, L., Chen, R., Wang, S., Ma, Z., & Li, G. (2023). Mechanisms of diabetic foot ulceration: A review. Journal of Diabetes, 15(4), 299–312. https://doi.org/10.1111/1753-0407.13372
Edwards, M. L. (2010). Hyperbaric oxygen therapy. Part 1: History and principles. Journal of Veterinary Emergency and Critical Care, 20(3), 284–288. https://doi.org/10.1111/j.1476-4431.2010.00535.x
Everett, E., & Mathioudakis, N. (2018). Update on management of diabetic foot ulcers. Annals of the New York Academy of Sciences, 1411(1), 153–165. https://doi.org/10.1111/nyas.13569
Gill, A. L., & Bell, C. N. (2004). Hyperbaric oxygen: Its uses, mechanisms of action and outcomes. QJM: An International Journal of Medicine, 97(7), 385–395. https://doi.org/10.1093/qjmed/hch074
Heyboer, M., III, Sharma, D., Santiago, W., & McCulloch, N. (2017). Hyperbaric oxygen therapy: Side effects defined and quantified. Advances in Wound Care, 6(6), 210–224. https://doi.org/10.1089/wound.2016.0718
Kranke, P., Bennett, M. H., Martyn-St James, M., Schnabel, A., Debus, S. E., & Weibel, S. (2015). Hyperbaric oxygen therapy for chronic wounds. Cochrane Database of Systematic Reviews, 2015(6), CD004123. https://doi.org/10.1002/14651858.CD004123.pub4
Lim, J. Z., Ng, N. S., & Thomas, C. (2017). Prevention and treatment of diabetic foot ulcers. Journal of the Royal Society of Medicine, 110(3), 104–109. https://doi.org/10.1177/0141076816688346
Lipsky, B. A., Berendt, A. R., Cornia, P. B., Pile, J. C., Peters, E. J., Armstrong, D. G., Deery, H. G., Embil, J. M., Joseph, W. S., Karchmer, A. W., Pinzur, M. S., & Senneville, E. (2012). 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clinical Infectious Diseases, 54(12), e132–e173. https://doi.org/10.1093/cid/cis346
Löndahl, M., Katzman, P., Nilsson, A., & Hammarlund, C. (2010). Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care, 33(5), 998–1003. https://doi.org/10.2337/dc09-1754
McDermott, K., Fang, M., Boulton, A. J. M., Selvin, E., & Hicks, C. W. (2023). Etiology, epidemiology, and disparities in the burden of diabetic foot ulcers. Diabetes Care, 46(1), 209–221. https://doi.org/10.2337/dci22-0043
Moreira Da Cruz, D. L., Oliveira-Pinto, J., & Mansilha, A. (2022). The role of hyperbaric oxygen therapy in the treatment of diabetic foot ulcers: A systematic review with meta-analysis of randomized controlled trials on limb amputation and ulcer healing. International Angiology, 41(1), 63–73. https://doi.org/10.23736/S0392-9590.21.04722-2
National Institute for Health and Care Excellence. (2023). Diabetic foot problems: Prevention and management. NICE.
Ortega, M. A., Fraile-Martínez, O., García-Montero, C., Callejón-Peláez, E., Sáez, M. A., Álvarez-Mon, M. A., García-Honduvilla, N., Monserrat, J., Álvarez-Mon, M., Buján, J., & Canals, M. L. (2021). A general overview on hyperbaric oxygen therapy: Applications, mechanisms and translational opportunities. Medicina, 57(9), 864. https://doi.org/10.3390/medicina57090864
Rehman, Z. U., Khan, J., & Noordin, S. (2023). Diabetic foot ulcers: Contemporary assessment and management. Journal of the Pakistan Medical Association, 73(7), 1480–1487. https://doi.org/10.47391/JPMA.6634
Sen, S., & Sen, S. (2021). Therapeutic effects of hyperbaric oxygen: Integrated review. Medical Gas Research, 11(1), 30–33. https://doi.org/10.4103/2045-9912.310057
Sharma, R., Sharma, S. K., Mudgal, S. K., Jelly, P., & Thakur, K. (2021). Efficacy of hyperbaric oxygen therapy for diabetic foot ulcer: A systematic review and meta-analysis of controlled clinical trials. Scientific Reports, 11, 2189. https://doi.org/10.1038/s41598-021-81886-1
Stoekenbroek, R. M., Santema, T. B., Legemate, D. A., Ubbink, D. T., Van Den Brink, A., & Koelemay, M. J. (2014). Hyperbaric oxygen for the treatment of diabetic foot ulcers: A systematic review. European Journal of Vascular and Endovascular Surgery, 47(6), 647–655. https://doi.org/10.1016/j.ejvs.2014.03.005
Vahabi, A., Mert, M., Erdem, H. A., Yıldırım Şimşir, I., Taşbakan, M. I., & Öztürk, A. M. (2023). Safe use of hyperbaric oxygen therapy in the treatment of diabetic foot ulcers: A multidisciplinary approach to minimize adverse effects. Interdisciplinary Perspectives on Infectious Diseases, 2023, 9154038. https://doi.org/10.1155/2023/9154038
Zhang, Y., Zhou, Y., Jia, Y., Wang, T., & Meng, D. (2023). Adverse effects of hyperbaric oxygen therapy: A systematic review and meta-analysis. Frontiers in Medicine, 10, 1160774. https://doi.org/10.3389/fmed.2023.1160774
Zhang, Z., Zhang, W., Xu, Y., & Liu, D. (2022). Efficacy of hyperbaric oxygen therapy for diabetic foot ulcers: An updated systematic review and meta-analysis. Asian Journal of Surgery, 45(1), 68–78. https://doi.org/10.1016/j.asjsur.2021.07.047
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Joanna Kozak, Agata Pszczółka, Patryk Matuszczak, Kacper Melka, Gabriela Bajor, Mikołaj Szulewski, Wiktoria Jurczyk-Florkiewicz, Zofia Gniadek, Patrycja Machno, Aleksandra Salagierska

This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.

